IL6 and breast cancer: Secretory ANXA2 in breast tumor serum creates a favorable environment for breast cancer cell survival and colonization in the brain through the activation of MAPK, NF-κB, and STAT3 signaling in macrophages, which results in the production of the chemokines IL-6 and TNFα34.